Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Liquidia Corporation

Liquidia Corporation (LQDA) Stock Overview

Explore Liquidia Corporation’s financial performance, market position, analyst ratings, and future outlook.

LQDA●NASDAQ
HealthcareMedical - Pharmaceuticals
$66.43
$0.45(0.67%)
U.S. Market opens in 3h 32m

Liquidia Corporation (LQDA)

Meyka AI Score

Z

Key Financials

Market Cap5.9B
P/E Ratio42.58
EPS (TTM)$1.37
ROE1.50%
Fundamental Analysis

AI Price Forecasts

1 Month$64.94
3 Months$94.01
1 Year Target$80.25

LQDA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Liquidia Corporation (NASDAQ: LQDA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Liquidia Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LQDA on the NASDAQ shows an RSI of 39.66, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $80.25 for the NASDAQ listing.

Key metrics behind Liquidia Corporation's NASDAQ-traded stock include a P/E ratio of 42.58 and a market capitalization of 5.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LQDA on the NASDAQ.

Price Performance (NASDAQ: LQDA)

1-Day Change
-0.67%
5-Day Change
1.16%
1-Month Change
-3.19%
3-Month Change
-12.00%
6-Month Change
82.45%
Year-to-Date (YTD) Change
92.61%
1-Year Change
190.09%
3-Year Change
936.35%
5-Year Change
2455.00%
All-Time (Max) Change
498.47%

Contact Information

https://www.liquidia.com
919 328 4400
419 Davis Drive, Morrisville, NC, 27560

Company Facts

2,160 Employees
IPO DateJul 26, 2018
CountryUS
Actively Trading

Frequently Asked Questions